Literature DB >> 12414720

CD45: a critical regulator of signaling thresholds in immune cells.

Michelle L Hermiston1, Zheng Xu, Arthur Weiss.   

Abstract

Regulation of tyrosine phosphorylation is a critical control point for integration of environmental signals into cellular responses. This regulation is mediated by the reciprocal actions of protein tyrosine kinases and phosphatases. CD45, the first and prototypic receptor-like protein tyrosine phosphatase, is expressed on all nucleated hematopoietic cells and plays a central role in this process. Studies of CD45 mutant cell lines, CD45-deficient mice, and CD45-deficient humans initially demonstrated the essential role of CD45 in antigen receptor signal transduction and lymphocyte development. It is now known that CD45 also modulates signals emanating from integrin and cytokine receptors. Recent work has focused on regulation of CD45 expression and alternative splicing, isoform-specific differences in signal transduction, and regulation of phosphatase activity. From these studies, a model is emerging in which CD45 affects cellular responses by controlling the relative threshold of sensitivity to external stimuli. Perturbation of this function may contribute to autoimmunity, immunodeficiency, and malignancy. Moreover, recent advances suggest that modulation of CD45 function can have therapeutic benefit in many disease states.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12414720     DOI: 10.1146/annurev.immunol.21.120601.140946

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  300 in total

1.  The multiple causes of human SCID.

Authors:  Rebecca H Buckley
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

2.  A conserved role for intragenic DNA methylation in alternative pre-mRNA splicing.

Authors:  Shalini Oberdoerffer
Journal:  Transcription       Date:  2012 May-Jun

Review 3.  Diversity in immunological synapse structure.

Authors:  Timothy J Thauland; David C Parker
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

4.  TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing.

Authors:  Ryan J Marina; David Sturgill; Marc A Bailly; Morgan Thenoz; Garima Varma; Maria F Prigge; Kyster K Nanan; Sanjeev Shukla; Nazmul Haque; Shalini Oberdoerffer
Journal:  EMBO J       Date:  2015-12-28       Impact factor: 11.598

5.  Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling.

Authors:  Francesca Gasparrini; Christoph Feest; Andreas Bruckbauer; Pieta K Mattila; Jennifer Müller; Lars Nitschke; Dennis Bray; Facundo D Batista
Journal:  EMBO J       Date:  2015-12-15       Impact factor: 11.598

6.  Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells.

Authors:  C Pokoyski; T Lienen; S Rother; E Schock; A Plege-Fleck; R Geffers; R Schwinzer
Journal:  Genes Immun       Date:  2015-09-10       Impact factor: 2.676

7.  The lectin Jacalin induces human B-lymphocyte apoptosis through glycosylation-dependent interaction with CD45.

Authors:  Bruce Yong Ma; Kaori Yoshida; Makoto Baba; Motohiro Nonaka; Shogo Matsumoto; Nobuko Kawasaki; Shinji Asano; Toshisuke Kawasaki
Journal:  Immunology       Date:  2008-10-30       Impact factor: 7.397

8.  Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus.

Authors:  Elizabeth C Jury; Panagiotis S Kabouridis; Fabian Flores-Borja; Rizgar A Mageed; David A Isenberg
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

9.  (211)Astatine-Conjugated Monoclonal CD45 Antibody-Based Nonmyeloablative Conditioning for Stem Cell Gene Therapy.

Authors:  Christopher R Burtner; Devikha Chandrasekaran; Erlinda B Santos; Brian C Beard; Jennifer E Adair; Donald K Hamlin; D Scott Wilbur; Brenda M Sandmaier; Hans-Peter Kiem
Journal:  Hum Gene Ther       Date:  2015-06       Impact factor: 5.695

10.  PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background.

Authors:  Julie Zikherman; Michelle Hermiston; David Steiner; Kiminori Hasegawa; Andrew Chan; Arthur Weiss
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.